Skip Navigation LinksUSZikaPregnancyRegistry

Zika

US ZIKA PREGNANCY AND INFANT REGISTRY

The U.S. Centers for Disease Control and Prevention (CDC) has established a national U.S. Zika Pregnancy and Infant Registry to address questions about Zika-associated birth defects and other pregnancy outcomes. All data reported to the U.S. Zika Pregnancy and Infant Registry will be de-identified and healthcare provider participation is voluntary. The California Department of Public Health (CDPH) is participating in the U.S. Zika Pregnancy and Infant Registry and is the point of contact for California data submission to CDC. CDPH is working with local health departments and healthcare providers to complete the U.S. Zika Pregnancy and Infant Registry data collection forms for submission to CDC.

U.S. Zika Pregnancy and Infant Registry: How to Participateā€‹

The U.S. Zika Pregnancy and Infant Registry potential data collection points include the time of maternal diagnosis, second trimester, third trimester, delivery, and infant follow-up at 2, 6, 12, 18 and 24 months.

Eligibility for Inclusion in the Registry

  • Pregnant women in the United States with laboratory evidence of Zika virus infection (positive or equivocal test results, regardless of whether they have symptoms) and periconceptionally, prenatally or perinatally exposed infants born to these women.
  • Infants with laboratory evidence of congenital Zika virus infection (positive or equivocal test results, regardless of whether they have symptoms) and their mothers. ā€‹ā€‹ā€‹
Page Last Updated :